These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 26930405)

  • 21. Obesity and risk of new-onset atrial fibrillation after cardiac surgery.
    Zacharias A; Schwann TA; Riordan CJ; Durham SJ; Shah AS; Habib RH
    Circulation; 2005 Nov; 112(21):3247-55. PubMed ID: 16286585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Analysis of risk factors for all cause-mortality in Chinese emergency atrial fibrillation patients].
    Wang J; Yang YM; Zhu J; Zhang H; Shao XH; Huang B; Tian L
    Zhonghua Yi Xue Za Zhi; 2013 Sep; 93(36):2871-5. PubMed ID: 24373398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Incidence, prevalence, and mortality estimates for chronic atrial fibrillation in Turkish adults].
    Uyarel H; Onat A; Yüksel H; Can G; Ordu S; Dursunoğlu D
    Turk Kardiyol Dern Ars; 2008 Jun; 36(4):214-22. PubMed ID: 18765964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.
    Gallego P; Roldán V; Torregrosa JM; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY
    Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):312-8. PubMed ID: 22319005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prevalence, incidence, management and risks of atrial fibrillation in an elderly Chinese population: a prospective study.
    Li LH; Sheng CS; Hu BC; Huang QF; Zeng WF; Li GL; Liu M; Wei FF; Zhang L; Kang YY; Song J; Wang S; Li Y; Liu SW; Wang JG
    BMC Cardiovasc Disord; 2015 May; 15():31. PubMed ID: 25953603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors and prognostic implications of incident heart failure following the first diagnosis of atrial fibrillation in patients with structurally normal hearts: the Belgrade Atrial Fibrillation Study.
    Potpara TS; Polovina MM; Licina MM; Marinkovic JM; Lip GY
    Eur J Heart Fail; 2013 Apr; 15(4):415-24. PubMed ID: 23302606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New-onset atrial fibrillation at discharge in patients after coronary artery bypass surgery: short- and long-term morbidity and mortality.
    Tulla H; Hippeläinen M; Turpeinen A; Pitkänen O; Hartikainen J
    Eur J Cardiothorac Surg; 2015 Nov; 48(5):747-52. PubMed ID: 25602052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).
    Washam JB; Stevens SR; Lokhnygina Y; Halperin JL; Breithardt G; Singer DE; Mahaffey KW; Hankey GJ; Berkowitz SD; Nessel CC; Fox KA; Califf RM; Piccini JP; Patel MR;
    Lancet; 2015 Jun; 385(9985):2363-70. PubMed ID: 25749644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulmonary embolism in patients with transvenous cardiac implantable electronic device leads.
    Noheria A; Ponamgi SP; Desimone CV; Vaidya VR; Aakre CA; Ebrille E; Hu T; Hodge DO; Slusser JP; Ammash NM; Bruce CJ; Rabinstein AA; Friedman PA; Asirvatham SJ
    Europace; 2016 Feb; 18(2):246-52. PubMed ID: 25767086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atrial fibrillation at baseline and during follow-up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).
    Haywood LJ; Ford CE; Crow RS; Davis BR; Massie BM; Einhorn PT; Williard A;
    J Am Coll Cardiol; 2009 Nov; 54(22):2023-31. PubMed ID: 19926008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is atrial fibrillation associated with pulmonary embolism?
    Gex G; Gerstel E; Righini M; LE Gal G; Aujesky D; Roy PM; Sanchez O; Verschuren F; Rutschmann OT; Perneger T; Perrier A
    J Thromb Haemost; 2012 Mar; 10(3):347-51. PubMed ID: 22212132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors and clinical implications of atrial fibrillation in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation.
    Barbash IM; Minha S; Ben-Dor I; Dvir D; Torguson R; Aly M; Bond E; Satler LF; Pichard AD; Waksman R
    Catheter Cardiovasc Interv; 2015 Feb; 85(3):468-77. PubMed ID: 25323129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes after cardioversion and atrial fibrillation ablation in patients treated with rivaroxaban and warfarin in the ROCKET AF trial.
    Piccini JP; Stevens SR; Lokhnygina Y; Patel MR; Halperin JL; Singer DE; Hankey GJ; Hacke W; Becker RC; Nessel CC; Mahaffey KW; Fox KA; Califf RM; Breithardt G;
    J Am Coll Cardiol; 2013 May; 61(19):1998-2006. PubMed ID: 23500298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence and impact outcome of pulmonary embolism in critically ill patients with severe exacerbation of chronic obstructive pulmonary diseases.
    Bahloul M; Chaari A; Tounsi A; Baccouche N; Abid H; Chtara K; Ben Hamida C; Ghadhoune H; Dammak H; Chelly H; Bouaziz M
    Clin Respir J; 2015 Jul; 9(3):270-7. PubMed ID: 24612880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Atrial fibrillation: prevalence, risk factors and mortality in a large French population with 15 years of follow-up].
    Guize L; Thomas F; Bean K; Benetos A; Pannier B
    Bull Acad Natl Med; 2007; 191(4-5):791-803; discussion 803-5. PubMed ID: 18225434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin.
    Hijazi Z; Wallentin L; Siegbahn A; Andersson U; Alexander JH; Atar D; Gersh BJ; Hanna M; Harjola VP; Horowitz JD; Husted S; Hylek EM; Lopes RD; McMurray JJ; Granger CB;
    J Am Coll Cardiol; 2014 Jan 7-14; 63(1):52-61. PubMed ID: 24055845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term follow-up after catheter ablation of paroxysmal atrial fibrillation: the incidence of recurrence and progression of atrial fibrillation.
    Takigawa M; Takahashi A; Kuwahara T; Okubo K; Takahashi Y; Watari Y; Takagi K; Fujino T; Kimura S; Hikita H; Tomita M; Hirao K; Isobe M
    Circ Arrhythm Electrophysiol; 2014 Apr; 7(2):267-73. PubMed ID: 24610740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence and clinical predictors of pulmonary embolism in severe heart failure patients admitted to a coronary care unit.
    Darze ES; Latado AL; Guimarães AG; Guedes RA; Santos AB; de Moura SS; Passos LC
    Chest; 2005 Oct; 128(4):2576-80. PubMed ID: 16236926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased Risk of Atrial Fibrillation After Treatment for Differentiated Thyroid Carcinoma.
    Klein Hesselink EN; Lefrandt JD; Schuurmans EP; Burgerhof JG; Groen B; Gansevoort RT; van der Horst-Schrivers AN; Dullaart RP; Van Gelder IC; Brouwers AH; Rienstra M; Links TP
    J Clin Endocrinol Metab; 2015 Dec; 100(12):4563-9. PubMed ID: 26480284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mineralocorticoid receptor antagonists and cardiovascular mortality in patients with atrial fibrillation and left ventricular dysfunction: insights from the Atrial Fibrillation and Congestive Heart Failure Trial.
    O'Meara E; Khairy P; Blanchet MC; de Denus S; Pedersen OD; Levesque S; Talajic M; Ducharme A; White M; Racine N; Rouleau JL; Tardif JC; Roy D;
    Circ Heart Fail; 2012 Sep; 5(5):586-93. PubMed ID: 22798522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.